Benefits of Attending & Past Statistics
Industry Benefits of Supporting ESID 2024:
- Promotes cutting-edge scientific research
- Contributes to the advancement of Primary Immunodeficiency (PID) on an international level
- Offers a unique opportunity to exchange ideas with renowned professionals from across the world
- Provides an ideal networking forum
- Offers unique exposure to worldwide markets
ESID Attendance over the years
Statistics from ESID 2022 – Gothenburg & Online
Total Registrations
Total Countries
Total Participants In-Person
Total Participants Online
PARTICIPANTS BY WORLD REGIONS
TOP 10 COUNTRIES
0
UNITED KINGDOM
0
SWEDEN
0
GERMANY
0
UNITED STATES
0
ITALY
0
NETHERLANDS
0
FRANCE
0
SPAIN
0
TURKEY
0
SWITZERLAND
PARTICIPANTS BY PROFESSIONAL ROLE
Clinical Practitioner
Clinician Researcher
Other
Industry/ Corporate Professional
Resident/Research Fellow
Basic Science Researcher
Student
Nurse/Healthcare Practitioner
PARTICIPANTS BY PROFESSIONAL INTEREST
Immunology
Pediatrics
Other
Allergy & Clinical Immunology
Internal Medicine
Molecular Biology
Hematology
Biochemistry
Pharmacology
Rheumatology
PARTICIPANTS BY AGE
0%
18 - 30
0%
30 - 40
0%
40 - 50
0%
50 - 60
0%
60+